ARTV
Artiva Biotherapeutics
ARTV
ARTV
40 hedge funds and large institutions have $52.1M invested in Artiva Biotherapeutics in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 16
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
Holders
40
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.85M | |
| 2 | +$338K | |
| 3 | +$293K | |
| 4 |
Renaissance Technologies
New York
|
+$227K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$138K |
Top Sellers
| 1 | -$549K | |
| 2 | -$440K | |
| 3 | -$428K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$212K |
| 5 |
Goldman Sachs
New York
|
-$196K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – |
|
|||
52
Nisa Investment Advisors
St. Louis,
Missouri
| – |
|